Speb Adhesives Ltd. IPO Allotment Status: Check Overall Subscription & Steps to Verify Status

The IPO allotment process for Speb Adhesives is expected to be finalised today, on December 4, 2025. The book build issue of ₹33.73 crores was opened for subscribers on December 1, 2025, ahead of the NSE SME listing. The tentative listing date has been fixed for December 8, 2025. The bidding window for the Speb Adhesives Ltd. IPO closed on December 3, 2025.

The company is engaged in the manufacturing and distribution of synthetic rubber adhesives (solvent-based). 

Check Speb Adhesives Ltd. IPO Allotment Status on NSE and the registrar’s website.  

Procedure to Check Speb Adhesives Ltd. IPO Allotment Status Online On NSE

• Go to the NSE’s IPO allotment verification status page here. 
• Select “Equity & SME IPO bid details”.
• In Select Symbol, select “Speb Adhesives Ltd.”
• Enter your PAN No. and application No. 
• Click “Submit”.

Procedure to Check Speb Adhesives Ltd. IPO Allotment Status Online On MUFG Intime    (Registrar to the Issue)

• Click here to visit MUFG Intime’s application status page. 
• Under, Please select company, select “Speb Adhesives Ltd.”
• Enter any of the following details. 
• PAN
• App. No.
• DP/Client ID  
• Account No / IFSC
• Click “Submit”.

Speb Adhesives Ltd. IPO Details

• The Speb Adhesives Ltd. IPO was a book build issue of ₹33.73 crores, combining a fresh issue of 0.49 crore shares aggregating to ₹27.18 crores and an offer for sale (OFS) of 0.12 crore shares aggregating to ₹6.55 crores.
• The price band for the Speb Adhesives Ltd.
• The IPO is set at ₹52.00 to ₹56.00 per share.
• The lot size for applications is 2,000.
• The minimum investment amount necessary for retail/individual investors is ₹2,24,000.00 or 4,000 shares (based on the upper price). The minimum investment for HNIs is 3 lots (6,000 shares), aggregating to ₹3,36,000.
• The book running lead manager is Unistone Capital Pvt. Ltd., and the registrar of the issue is MUFG Intime India Pvt. Ltd. Kalpalabdhi Financial Private Limited is the Market Maker of the company. 

Speb Adhesives Ltd. IPO Overall Subscription Status

Speb Adhesives Ltd. saw an overall subscription of 2.34 times as per the NSE data as of December 3, 2025, at the end of the day. 

The public issue was subscribed: 

• 2.06x by QIB Ex Anchor investors 
• 4.09x by Non-Institutional Buyers
  • 4.88x by bNIIs (bids above ₹10L)
  • 2.51x by bNIIs (bids below ₹10L)
• 1.75x by retail individual investors (RIIs)

Explore other upcoming IPOs on NSE and BSE. 

Utilisation of Proceeds

The company proposes to utilise the net proceeds from the issue towards the following objectives: 

• ₹20.44 crores for part-financing the cost of establishing a new manufacturing facility to expand production capabilities of water-based adhesives at Survey no. 120, 121/1 and 121/2, Village Tambati, Taluka Khalapur, District Raigad, Maharashtra, India (new proposed facility)
• General corporate purposes

About Speb Adhesives Ltd.  

Speb Adhesives Ltd. is a company that is engaged in the manufacturing and distribution of synthetic rubber adhesives (solvent-based). The company offers both solvent-based and water-based adhesives. The portfolio includes premium bonding, spray-grade, and multi-purpose adhesives, as well as several other products. It follows a B2B model for selling products across sectors like automotive, packaging, footwear, woodworking, construction, and furniture. The company has a manufacturing facility at the MIDC Industrial Area in Taloja, Raigad, Maharashtra, with an installed capacity of 12,000 litres per day. 

Financially, the company reported: 

• Higher revenue of 5% and profit after tax (PAT) of 19% between the financial year ending with March 31, 2025 and March 31, 2024
• Assets of ₹31.88 crores as of 30 September 2025, and total income of ₹25.04 crores by this period
• Profit after tax (PAT) of ₹3.65 crores and EBITDA of ₹4.88 crores as of 30 September 2025

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.